Advertisements



5 Reasons Big Biotech Could Gain 25%-30%

Leerink analyst Geoff Porges sees 25% or better upside ahead for Big Biotech. Here's why.....»»

Category: blogSource: barronsMay 19th, 2017

7 Reasons to Add Rockwell Automation to Your Portfolio Now

Rockwell Automation (ROK) is poised to gain from positive estimate revisions and outlook. Shares of Rockwell Automation Inc. ROK, the original.....»»

Category: topSource: zacksMay 18th, 2017

Biotech Forum Daily Digest: Keytruda Continues To Gain Momentum. Revisiting Amicus Therapeutics After Earnings

Biotech Forum Daily Digest: Keytruda Continues To Gain Momentum. Revisiting Amicus Therapeutics After Earnings.....»»

Category: topSource: seekingalphaMay 12th, 2017

Gilead Sciences shares fall after earnings miss

Gilead Sciences Inc. shares declined in the extended session Tuesday after the biotech company's quarterly earnings fell short of Wall Street estimates. Gilead shares fell 3.2% to $66.39 after hours, following a 0.7% gain in the regular session. .....»»

Category: topSource: marketwatchMay 2nd, 2017

Biogen: Stuck in a Rut?

Shares of Biogen (BIIB) are soaring today after the biotech giant released earnings today. Despite the big gain, shares o.....»»

Category: blogSource: barronsApr 25th, 2017

Jeff Reeves"s Strength in Numbers: Why biotech stocks are a healthy bet in a sickly broader market

Jeff Reeves lists 4 reasons to invest in biotech plays right now......»»

Category: topSource: marketwatchApr 20th, 2017

3 Reasons To Buy Proofpoint, According To DA Davidson

Need a reason to buy shares of Proofpoint Inc (NASDAQ: PFPT) despite a 45 percent gain over the past year? Analysts at DA Davidson are offering three. Latest.....»»

Category: blogSource: benzingaApr 19th, 2017

6 Reasons Gilead Sciences Could Be the World"s Most Perfect Stock

This biotech blue chip could be a perfect addition to your portfolio......»»

Category: topSource: foxnewsApr 3rd, 2017

Biotech Firm Says It’s Close to a Cure for the Cancer that Killed Steve Jobs

A "multi-hundred million" opportunity. A French biotech firm is hoping to gain approval within months for a nuclear medicine targeting the type of cancer that killed Steve Jobs. The drug c.....»»

Category: europeSource: fortuneMar 16th, 2017

Biotech Forum Daily Digest: Biotech Continues To Gain Momentum. Alzheimer"s Research Continues To Be "Black Hole"

Biotech Forum Daily Digest: Biotech Continues To Gain Momentum. Alzheimer"s Research Continues To Be "Black Hole".....»»

Category: topSource: seekingalphaFeb 21st, 2017

5 reasons to bank on biotech stocks now

Start with valuations look reasonable, buyouts are likely and you shouldn’t sweat Donald Trump’s rhetoric, says Jeff Reeves......»»

Category: topSource: moneycentralFeb 2nd, 2017

Jeff Reeves"s Strength in Numbers: 5 reasons to bank on biotech stocks now

Start with valuations look reasonable, buyouts are likely and you shouldn’t sweat Donald Trump’s rhetoric, says Jeff Reeves......»»

Category: topSource: marketwatchFeb 2nd, 2017

Biotech Stocks Gain on Latest Trump Drug Price Statements

President Trump continues to double down on his campaign promises, and his latest statements regarding drug prices and regulation have sent biotech stocks higher.....»»

Category: topSource: zacksJan 31st, 2017

Why Did Restaurant Brands International Inc. Shares Gain 30% in 2016?

The company's two brands had a strong year -- albeit for different reasons......»»

Category: topSource: foxnewsJan 21st, 2017

6 Excellent Reasons to Launch Your Own Facebook Live Show in 2017

How to use Facebook Live to gain international exposure and deliver a better brand experience to your customers......»»

Category: topSource: incJan 9th, 2017

2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016

A rival's pain was this drugmaker's big gain in 2016......»»

Category: topSource: foxnewsJan 6th, 2017

4 Reasons to Buy Horizon Bancorp (HBNC) Stock Right Now

Shares of Horizon Bancorp (HBNC) surged over 50% year to date, significantly outpacing the 35.3% gain fo.....»»

Category: topSource: zacksDec 30th, 2016

5 Reasons Why You Should Buy DeVry Education (DV) Now

IL-based DeVry Education Group Inc. (DV) is one such company to gain from Trump's win and strength in several of the key areas. Thus, adding the stock to your portfolio should be a prudent move. The U.S. presidentia.....»»

Category: topSource: zacksDec 29th, 2016

Actelion shares gain on report of progress in Sanofi talks

ZURICH (Reuters) - Swiss biotech group Actelion's shares rose by more than 3 percent on Wednesday following a report that talks with Sanofi are making progress, increasing optimism that the two will strike a deal......»»

Category: topSource: reutersDec 21st, 2016

Why Biogen"s new CEO stands to gain from an acquisition

Biogen’s announcement Monday that Chief Commercial Officer Michel Vounatsos will take over as CEO has rekindled a debate over whether the Massachusetts-based biotech could be acquired in its current, precarious state. But at least one thing is clea.....»»

Category: topSource: bizjournalsDec 20th, 2016

Stock Market Roundup Dec. 7: Stocks Gain Despite Biotech Sell-Off

Zacks.....»»

Category: topSource: redinewsDec 7th, 2016